News

Cell Therapies Pty Ltd and Peter MacCallum Cancer Centre presents “First in Human: In-vivo Imaging of Labelled CAR T Cells with Dual PET-MR” at ASCO 2020

Cell Therapies Pty Ltd and Peter MacCallum Cancer Centre, in collaboration with RMIT University, the…

Cell TherapiesMay 29, 2020

News

Melbourne – Peter Mac Open for Trials, Cell Therapies Open for Business

While hospitals in many parts of the world have faced unprecedented challenges with routine clinical…

Cell TherapiesMay 28, 2020

News

Kymriah® to be manufactured at Cell Therapies Pty Ltd, marking Australia’s first on-shore commercial production of CAR T therapy

Health Minister Greg Hunt announces funding for Kymriah today at the Peter MacCallum Cancer Institute…

Cell TherapiesJanuary 28, 2020

News

Cell Therapies attending Phacilitate

Cell Therapies Pty Ltd will be attending the Phacilitate Leaders World Conference, part of Advanced…

Cell TherapiesDecember 2, 2019

News

Cell Therapies attending ISCT Paris

Cell Therapies Pty Ltd will be attending the International Society for Cell & Gene Therapy…

Cell TherapiesDecember 2, 2019

News

Cell Therapies Pty Ltd Becomes the First Australian Company Awarded a Commercial CAR-T TGA License

For the first time in Australia, Cell Therapies Pty Ltd (CTPL), a recognised leader in the…

Cell TherapiesAugust 29, 2019

News

ISCT Breakfast Session with Avrobio

Cell Therapies Pty Ltd hosted a very unique breakfast session at ISCT on Thursday 30th…

Cell TherapiesJune 14, 2019

News

Open House for ISCT 2019

Cell Therapies Pty Ltd will be holding an Open House on Tuesday, 28 May 2019…

Cell TherapiesFebruary 21, 2019

News

A new video explains the elegant way that CAR-T treatment works!

Cell TherapiesDecember 19, 2018

News

New cancer treatment approved in Australia

(19 Dec 18) Novartis Australia has announced the TGA approval of Kymriah® (tisagenlecleucel), for the…

Cell TherapiesDecember 19, 2018

News

Dr Dawn Driscoll appointed as CEO at Cell Therapies Pty Ltd

Cell Therapies Pty Ltd is delighted to announce the appointment of Dr Dawn Driscoll as…

Cell TherapiesOctober 4, 2017

News

CTPL awarded Australian Global Innovation Linkages programme grant

Melbourne, Australia 26 June 2017: Cell Therapies has been awarded $1,000,000 in funding by the…

Cell TherapiesJune 26, 2017

Filter

Cell Therapies and Teijin Announce Strategic Collaboration to Expand Access to Advanced Cell and Gene Therapies in Japan and the Asia Pacific Region

Cell Therapies and Viral Vector Manufacturing Facility (VVMF) enters strategic collaboration

CTPL sign MoU with Xellera to Fast-Track CGT Access across APAC

News

Cell Therapies Pty Ltd and Peter MacCallum Cancer Centre presents “First in Human: In-vivo Imaging of Labelled CAR T Cells with Dual PET-MR” at ASCO 2020

Melbourne – Peter Mac Open for Trials, Cell Therapies Open for Business

Kymriah® to be manufactured at Cell Therapies Pty Ltd, marking Australia’s first on-shore commercial production of CAR T therapy

Cell Therapies attending Phacilitate

Cell Therapies attending ISCT Paris

Cell Therapies Pty Ltd Becomes the First Australian Company Awarded a Commercial CAR-T TGA License

ISCT Breakfast Session with Avrobio

Open House for ISCT 2019

A new video explains the elegant way that CAR-T treatment works!

New cancer treatment approved in Australia

Dr Dawn Driscoll appointed as CEO at Cell Therapies Pty Ltd

CTPL awarded Australian Global Innovation Linkages programme grant

Unrivalled experience and service from a global leader in cell and gene therapy manufacturing

Services

Helpful Links

Corporate